International Variation in Lung Cancer Mortality Rates and Trends among Women

Torre, Lindsey A.; Siegel, Rebecca L.; Ward, Elizabeth; Jemal, Ahmedin

doi:10.1158/1055-9965.epi-13-1220

Cited by 57 publications

(46 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Lung cancer trends in women lag behind those in males because women began smoking later. In countries with the earliest uptake of smoking among women (e.g., US, UK, and Australia), lung cancer mortality rates have peaked, whereas they continue to climb in countries where women began smoking later (9). Although overall rates among women are increasing, rates among younger women are beginning to decrease in recent years in many countries, indicating early successes in tobacco control (9).…”

Section: Lung and Bronchusmentioning

confidence: 99%

“…In countries with the earliest uptake of smoking among women (e.g., US, UK, and Australia), lung cancer mortality rates have peaked, whereas they continue to climb in countries where women began smoking later (9). Although overall rates among women are increasing, rates among younger women are beginning to decrease in recent years in many countries, indicating early successes in tobacco control (9). In some LMICs where the tobacco epidemic is newer or has not yet taken hold, including Africa and parts of Asia, lung cancer mortality has not begun to rise, and could be arrested through swift application of tobacco control measures (9).…”

Section: Lung and Bronchusmentioning

confidence: 99%

“…Although overall rates among women are increasing, rates among younger women are beginning to decrease in recent years in many countries, indicating early successes in tobacco control (9). In some LMICs where the tobacco epidemic is newer or has not yet taken hold, including Africa and parts of Asia, lung cancer mortality has not begun to rise, and could be arrested through swift application of tobacco control measures (9).…”

Section: Lung and Bronchusmentioning

confidence: 99%

See 2 more Smart Citations

Global Cancer Incidence and Mortality Rates and Trends—An Update

Torre

Siegel

Ward

et al. 2016

Cancer Epidemiology, Biomarkers &Amp; Prevention

Self Cite

3,122

2,186

View full text Add to dashboard Cite

There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for [2003][2004][2005][2006][2007]. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low-and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.Cancer Epidemiol Biomarkers Prev; 25(1); 16-27. Ó2015 AACR.

show abstract

Section: Lung and Bronchusmentioning

confidence: 99%

Section: Lung and Bronchusmentioning

confidence: 99%

Section: Lung and Bronchusmentioning

confidence: 99%

See 1 more Smart Citation

Global Cancer Incidence and Mortality Rates and Trends—An Update

Torre

Siegel

Ward

et al. 2016

Cancer Epidemiology, Biomarkers &Amp; Prevention

Self Cite

3,122

2,186

View full text Add to dashboard Cite

show abstract

“…En hombres, el cáncer de pulmón representa el tumor más frecuente (1,1 millones de casos, 16,5% del total) (Ferlay et al, 2013;Malvezzi et al, 2014;Steliarova-Foucher, O'Callaghan y Ferlay, 2012;Torre et al, 2014). La tasas de incidencia en mujeres son generalmente más bajas que en hombres.…”

Section: Epidemiología Del Cáncer De Pulmón En Mujeresunclassified

El cáncer de pulmón en mujeres

Felip

2015

Arbor

View full text Add to dashboard Cite

Hospital Universitari Vall d'Hebronefelip@vhebron.net RESUMEN: El cáncer de pulmón es la enfermedad maligna más frecuente en el mundo. En los últimos diez años en España, la mortalidad por cáncer de pulmón ha aumentado un 20% en las mujeres frente a un 5% en los hombres, debido a los cambios recientes de patrones de hábito tabáquico entre ambos sexos. El tabaco sigue siendo la causa única más importante de una enfermedad prevenible en un alto porcentaje de casos. Es muy importante que la población conozca esta realidad y que modifique el estilo de vida, eliminado el tabaquismo, para poder detener esta epidemia que representa el cáncer de pulmón. En este artículo se revisarán aspectos epidemiológicos, así como factores de riesgo, características y pronóstico de las mujeres con cáncer de pulmón, con una especial atención a la población española. PALABRAS CLAVE: adenocarcinoma; EGFR; tabaco.ABSTRACT: Lung cancer is the most frequent malignant disease in the world. Over the last ten years lung cancer mortality has risen in Spain by 20% among women compared with 5% among men. This is due to recent changes in both genders' smoking habits. Tobacco is still the single most important cause of a preventable disease in a high percentage of cases. It is extremely important that the population is aware of this and that people modify their lifestyle accordingly, giving up smoking in order to halt the lung cancer epidemic. In this article, we review epidemiological aspects, as well as risk factors, characteristics and the prognosis for women with lung cancer, focusing particularly on the Spanish population.

show abstract

“…The patterns and trends also link to inherent disparities and widening gaps between and within countries in levels of health infrastructure and medical practice. [2][3][4][5][6][7][8][9][10][11][12] Cancer mortality rates are declining in most highly developed countries, largely due to recent successes in the control of common cancers through programs of effective prevention, early detection, and treatment. In contrast, mortality rates of many types of cancer, including breast cancer and prostate cancer, are still increasing in transitioning countries, or at best stabilizing.…”

Section: Introductionmentioning

confidence: 99%

Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010

Cao

Bray

Beltrán‐Sánchez

et al. 2017

BMJ

View full text Add to dashboard Cite

Objective To quantify the impact of cancer (all cancers combined and major sites) compared with cardiovascular disease (CVD) on longevity worldwide during 1981-2010. Design Retrospective demographic analysis using aggregated data. Setting National civil registration systems in member states of the World Health Organization. Participants 52 populations with moderate to high quality data on cause specific mortality. Main outcome measures Disease specific contributions to changes in life expectancy in ages 40-84 (LE40-84) over time in populations grouped by two levels of Human Development Index (HDI) values. Results Declining CVD mortality rates during 1981-2010 contributed to, on average, over half of the gains in LE40-84; the corresponding gains were 2.3 (men) and 1.7 (women) years, and 0.5 (men) and 0.8 (women) years in very high and medium and high HDI populations, respectively. Declines in cancer mortality rates contributed to, on average, 20% of the gains in LE40-84, or 0.8 (men) and 0.5 (women) years in very high HDI populations, and to over 10% or 0.2 years (both sexes) in medium and high HDI populations. Declining lung cancer mortality rates brought about the largest LE40-84 gain in men in very high HDI populations (up to 0.7 years in the Netherlands), whereas in medium and high HDI populations its contribution was smaller yet still positive. Among women, declines in breast cancer mortality rates were largely responsible for the improvement in longevity, particularly among very high HDI populations (up to 0.3 years in the United Kingdom). In contrast, losses in LE40-84 were observed in many medium and high HDI populations as a result of increasing breast cancer mortality rates. Conclusions The control of CVD has led to substantial gains in LE40-84 worldwide. The inequality in improvement in longevity attributed to declining cancer mortality rates reflects inequities in implementation of cancer control, particularly in less resourced populations and in women. Global actions are needed to revitalize efforts for cancer control, with a specific focus on less resourced countries.

show abstract

International Variation in Lung Cancer Mortality Rates and Trends among Women

Cited by 57 publications

References 33 publications

Global Cancer Incidence and Mortality Rates and Trends—An Update

Global Cancer Incidence and Mortality Rates and Trends—An Update

El cáncer de pulmón en mujeres

Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010

Contact Info

Product

Resources

About